Danaher Corporation (DHR)
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
$226.34-3.66%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Diagnostics & ResearchSnapshot 2026-11-04
QuarterlyIQ Insights · DHR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||||
| Revenues | 25,608.0 | 24,568.0 | 23,875.0 | 23,890.0 | 26,643.0 | 24,802.0 | 22,284.0 | 17,911.1 | 16,882.4 | 16,882.4 | 16,882.4 | 20,563.1 | 18,260.4 | 18,260.4 | 18,260.4 | 16,090.5 | 12,262.6 | 12,697.5 |
| Total Revenues | — | — | — | — | — | — | — | — | 16,882.4 | 16,882.4 | 16,882.4 | 20,563.1 | 18,260.4 | 18,260.4 | 18,260.4 | 16,090.5 | 12,262.6 | 12,697.5 |
| Cost of Revenues | 10,603.0 | 10,045.0 | 9,669.0 | 9,856.0 | 10,455.0 | 9,563.0 | 9,809.0 | 7,927.4 | 7,547.8 | 7,547.8 | 7,547.8 | 9,800.6 | 8,846.1 | 8,846.1 | 8,846.1 | 7,913.9 | 6,475.0 | 6,757.3 |
| Gross Profit | 15,005.0 | 14,523.0 | 14,206.0 | 14,034.0 | 16,188.0 | 15,239.0 | 12,475.0 | 9,983.7 | 9,334.6 | 9,334.6 | 9,334.6 | 10,762.5 | 9,414.3 | 9,414.3 | 9,414.3 | 8,176.7 | 5,787.6 | — |
| Operating Expenses & Income | ||||||||||||||||||
| Selling, General & Admin | 8,117.0 | 8,235.0 | 7,759.0 | 7,329.0 | 7,124.0 | 6,817.0 | 6,896.0 | 5,588.3 | 5,624.3 | 5,608.6 | 5,608.6 | 6,054.3 | 5,181.2 | 5,181.2 | 5,181.2 | 4,607.7 | 3,304.1 | 3,345.3 |
| R&D Expenses | 1,670.0 | 1,598.0 | 1,584.0 | 1,503.0 | 1,528.0 | 1,498.0 | 1,348.0 | 1,126.0 | 975.1 | 975.1 | 975.1 | 1,239.1 | 1,137.9 | 1,137.9 | 1,137.9 | 1,018.5 | 696.0 | 725.4 |
| Operating Income | 5,218.0 | 4,690.0 | 4,863.0 | 5,202.0 | 7,536.0 | 6,377.0 | 4,231.0 | 3,269.4 | 2,735.2 | 2,750.9 | 2,750.9 | 3,469.1 | 3,165.1 | 3,165.1 | 3,165.1 | 2,617.2 | 1,787.5 | 1,869.5 |
| Earnings from Continuing Operations | ||||||||||||||||||
| Interest Expense | — | 265.0 | 278.0 | 286.0 | 204.0 | 231.0 | 275.0 | 108.6 | 184.4 | 184.4 | 184.4 | 162.8 | 157.5 | 157.5 | 157.5 | 141.6 | 126.5 | 130.2 |
| Interest & Investment Income | 132.0 | 30.0 | 117.0 | 303.0 | 41.0 | 11.0 | 71.0 | 139.0 | 0.2 | 0.2 | 0.2 | 5.3 | 3.2 | 3.2 | 3.2 | 5.1 | 10.0 | 10.0 |
| Net Interest Expenses | — | — | — | (17.0) | 163.0 | 220.0 | 204.0 | (30.4) | 184.2 | 184.2 | 184.2 | 157.5 | 154.3 | 154.3 | 154.3 | 136.5 | 116.5 | 120.2 |
| Asset Writedown | — | 562.0 | 265.0 | 77.0 | 0.0 | 10.0 | 22.0 | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | 4,818.0 | 4,233.0 | 4,646.0 | 5,044.0 | 7,146.0 | 6,511.0 | 4,495.0 | 3,305.3 | 2,611.3 | 2,611.3 | 2,611.3 | 3,324.0 | 3,010.8 | 3,010.8 | 3,010.8 | 2,447.8 | 1,671.0 | 1,749.3 |
| Income Tax Expense | 529.0 | 633.0 | 747.0 | 823.0 | 818.0 | 1,064.0 | 849.0 | 873.0 | 457.9 | 457.9 | 457.9 | 725.3 | 711.5 | 711.5 | 711.5 | 512.6 | 404.5 | 431.7 |
| Net Income | ||||||||||||||||||
| Net Income | 4,331.0 | 3,614.0 | 3,899.0 | 4,764.0 | 7,209.0 | 6,433.0 | 3,646.0 | 3,008.2 | 2,553.7 | 2,553.7 | 2,553.7 | 3,357.4 | 2,392.2 | 2,392.2 | 2,392.2 | 2,172.3 | 1,317.6 | 1,317.6 |
| Per Share | ||||||||||||||||||
| Basic EPS | 6.15 | 5.07 | 5.33 | 6.44 | 9.80 | 8.77 | 4.97 | 4.11 | 3.69 | 3.69 | 3.69 | 4.81 | 3.45 | 3.45 | 3.45 | 3.21 | 2.06 | 4.13 |
| Diluted EPS | 6.13 | 5.05 | 5.29 | 6.38 | 9.66 | 8.61 | 4.89 | 4.05 | 3.65 | 3.65 | 3.65 | 4.74 | 3.36 | 3.36 | 3.36 | 3.11 | 1.98 | 3.95 |
| Revenue per Share | 36.23 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 703.8 | 712.7 | 731.0 | 736.5 | 725.1 | 714.6 | 706.2 | 715.0 | 691.2 | 691.2 | 691.2 | 698.1 | 693.4 | 693.4 | 693.4 | 676.2 | 638.7 | 319.4 |
| Diluted Weighted Avg Shares | 706.8 | 716.1 | 737.2 | 743.1 | 737.1 | 736.8 | 718.7 | 725.5 | 699.8 | 699.8 | 699.8 | 708.5 | 713.1 | 713.1 | 713.1 | 701.2 | 671.7 | 335.9 |
| Supplemental | ||||||||||||||||||
| EBITDA | — | — | — | 7,368.0 | 9,668.0 | 8,439.0 | 6,006.0 | 4,458.9 | 3,863.3 | 3,879.0 | 3,879.0 | 4,520.4 | 4,004.9 | 4,004.9 | 4,004.9 | 3,252.1 | 2,120.1 | — |
| EBIT | 5,218.0 | 4,690.0 | 4,863.0 | 5,202.0 | 7,536.0 | 6,377.0 | 4,231.0 | 3,269.4 | 2,735.2 | 2,750.9 | 2,750.9 | 3,469.1 | 3,165.1 | 3,165.1 | 3,165.1 | 2,617.2 | 1,787.5 | 1,869.5 |
| Effective Tax Rate | 11.0% | — | — | 16.3% | 11.4% | 16.3% | 18.9% | 26.4% | 17.5% | 17.5% | 17.5% | 21.8% | 23.6% | 23.6% | 23.6% | 20.9% | 24.2% | 24.7% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.